金域医学: 广州金域医学检验集团股份有限公司关于股东部分股份质押展期的公告

Summary of Key Points Core Viewpoint - The announcement details the extension of share pledges by the major shareholder of Guangzhou Kingmed Diagnostics Group Co., Ltd., indicating a significant portion of shares are pledged, which may impact the company's financial stability and investor confidence. Group 1: Share Pledge Details - The shareholder, Shengyutang, directly holds 21,000,000 shares, accounting for 4.53% of the total share capital of the company [1] - The current extension involves 8,580,000 shares, which represents 40.86% of Shengyutang's directly held shares and 1.85% of the company's total share capital [1] - After the extension, the total pledged shares by the controlling shareholder and related parties amount to 31,580,000 shares, which is 19.14% of their total holdings and 6.82% of the company's total share capital [1][6] Group 2: Pledge Status and Implications - As of the announcement date, the controlling shareholder, Liang Yaoming, and his associates have a cumulative pledge of shares, which includes Shengyutang and other investment partnerships [2] - The total number of pledged shares is 164,983,621, representing 35.61% of the total share capital, with 31,580,000 shares newly pledged [6] - The company will closely monitor the developments regarding these pledges and will disclose relevant information in accordance with regulations [6][7]